Results per Page:

Two doses of the HPV vaccine is all you need
Long-term immunity from human papillomavirus infections — and the deadly cancers they can drive — reached with just two jabs

When it comes to HPV vaccination, just once is enough
Galloway Lab, Human Biology Division

Dr. Denise Galloway elected Fellow of the American Association for Cancer Research Academy
Cancer biologist contributed basic and translational insights that made the cancer-preventive HPV vaccine possible

Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news

Learning to trust science with your life
Diseases like cancer and COVID-19 can be scary; leaning into the science helps you feel more empowered

Correlation is not (necessarily) causation
Or, how we know herpes doesn’t cause cervical cancer — and HPV does

Dr. Denise Galloway, expert in cancer-causing viruses, named 'Woman of Influence'
Puget Sound Business Journal recognizes researcher's impact, scientific leadership

How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations

Drs. Jeanne Ting Chowning, Denise Galloway receive Seattle AWIS awards
Honored for excellence in STEM education/outreach, science advancement and leadership

Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem

Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients

Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers

Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents

Fred Hutch epidemiologists receive $2.5M grant for first-ever study of therapeutic use for HPV vaccine
Could the preventive vaccine also be a therapy for anogenital precancers?

Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients

Health disparities workshops build bridges to better serve marginalized communities
Health disparities workshops build bridges to better serve marginalized communities

Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated

HPV vaccine boosts immune memory
A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection